Antimicrobial resistance: We need to act now

  01 October 2021

Antimicrobial drugs are undervalued for their revolutionary impact on human society. Their discovery in the early 20th century corresponds with a dramatic increase in global life expectancy. Where the world average lifespan would endure just 32 years in 1900, this had jumped to 73 by 2020. Thanks to the development of various classes of antimicrobial agents throughout the last century, death at the hands of bacterial infection has become significantly less of a risk.

However, the emergence of drug-resistant bacteria serves to dilute the effectiveness of antimicrobial agents.

With widespread availability of antibiotics, the risk of overuse, or even abuse of antimicrobials as a treatment option for non-bacterial infections has accelerated the ability of microorganisms to acquire resistance to antimicrobials. The use of antibiotics in animal rearing is also contributing to fueling AMR, as well as antimicrobial residues in the environment.

Further reading: AmCham EU
Author(s): Andrea Chiarello
Effective Surveillance  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University


Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!